Angiopoietins in angiogenesis

E Fagiani, G Christofori - Cancer letters, 2013 - Elsevier
Tie-1 and Tie-2 tyrosine kinase receptors are expressed specifically on vascular endothelial
cells and on a certain subtype of macrophages implicated in angiogenesis, thus, they have …

Novel drugs with high efficacy against tumor angiogenesis

S Qi, S Deng, Z Lian, K Yu - International Journal of Molecular Sciences, 2022 - mdpi.com
Angiogenesis is involved in physiological and pathological processes in the body. Tumor
angiogenesis is a key factor associated with tumor growth, progression, and metastasis …

Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1‐based vaccines to prevent it

AR Jensen, Y Adams, L Hviid - Immunological reviews, 2020 - Wiley Online Library
Malaria, a mosquito‐borne infectious disease caused by parasites of the genus Plasmodium
continues to be a major health problem worldwide. The unicellular Plasmodium‐parasites …

Targeting the ANGPT–TIE2 pathway in malignancy

H Huang, A Bhat, G Woodnutt, R Lappe - Nature Reviews Cancer, 2010 - nature.com
Angiopoietins (ANGPTs) are ligands of the endothelial cell receptor TIE2 and have crucial
roles in the tumour angiogenic switch. Increased expression of ANGPT2 relative to ANGPT1 …

The role of the Angiopoietins in vascular morphogenesis

M Thomas, HG Augustin - Angiogenesis, 2009 - Springer
Abstracts The Angiopoietin/Tie system acts as a vascular specific ligand/receptor system to
control endothelial cell survival and vascular maturation. The Angiopoietin family includes …

Signaling and functions of angiopoietin-1 in vascular protection

NPJ Brindle, P Saharinen, K Alitalo - Circulation research, 2006 - Am Heart Assoc
Angiopoietin-1 (Ang1) has powerful vascular protective effects: suppressing plasma
leakage, inhibiting vascular inflammation, and preventing endothelial death. Preclinical …

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

HT Yuan, EV Khankin, SA Karumanchi… - Molecular and cellular …, 2009 - Taylor & Francis
Angiopoietin 2 (Ang2) was originally shown to be a competitive antagonist for Ang1 of the
receptor tyrosine kinase Tie2 in endothelial cells (ECs). Since then, reports have conflicted …

A review of anti-angiogenic targets for monoclonal antibody cancer therapy

DH Kong, MR Kim, JH Jang, HJ Na, S Lee - International journal of …, 2017 - mdpi.com
Tumor angiogenesis is a key event that governs tumor progression and metastasis. It is
controlled by the complicated and coordinated actions of pro-angiogenic factors and their …

Targeting Tie2 in the tumor microenvironment: from angiogenesis to dissemination

CL Duran, L Borriello, GS Karagiannis, D Entenberg… - Cancers, 2021 - mdpi.com
Simple Summary The dissemination of cancer cells from their original location to distant
organs where they grow, a process called metastasis, causes more than 90% of cancer …

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell–matrix contacts

P Saharinen, L Eklund, J Miettinen, R Wirkkala… - Nature cell …, 2008 - nature.com
The receptor tyrosine kinase Tie2, and its activating ligand Angiopoietin-1 (Ang1), are
required for vascular remodelling and vessel integrity, whereas Ang2 may counteract these …